Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
Benign prostatic hyperplasia is a common disease in men aged over 50 years old, with an incidence increasing to more than 80% over the age of 70, that is increasingly going to attract pharmaceutical interest. Within conventional therapies, such as α-adrenoreceptor antagonists and 5α-reductase inhibi...
Main Authors: | Paolo Governa, Daniela Giachetti, Marco Biagi, Fabrizio Manetti, Luca De Vico |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2016-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/2698.pdf |
Similar Items
-
In-silico molecular designs to treat neurologic and ophthalmologic diseases caused by sorbitol excess: engineering the Agrobacterium vitis protein
by: Shonit Nair Sharma, et al.
Published: (2023-07-01) -
Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
by: Stephen B. Strum
Published: (2021-08-01) -
Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part II
by: Stephen B. Strum
Published: (2021-08-01) -
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials
by: Gianni Paulis, et al.
Published: (2021-12-01) -
The Role of Combination Therapy with α-Blockers and Hexanic Extract of <i>Serenoa repens</i> in the Treatment of LUTS/BPH
by: Cosimo De Nunzio, et al.
Published: (2022-12-01)